You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Profile for San Marino Patent: T202200202


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T202200202

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,174,074 Jan 19, 2035 Scynexis BREXAFEMME ibrexafungerp citrate
10,370,406 Jan 19, 2035 Scynexis BREXAFEMME ibrexafungerp citrate
10,927,142 Jan 19, 2035 Scynexis BREXAFEMME ibrexafungerp citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for San Marino Drug Patent SMT202200202

Last updated: August 3, 2025


Introduction

San Marino’s patent SMT202200202 pertains to a pharmaceutical invention intended for medical treatment applications. As patent landscapes increasingly influence strategic decisions related to intellectual property (IP) management and market entry, a comprehensive analysis of the patent’s scope, claims, and its broader patent environment is vital for stakeholders. This article dissects SMT202200202’s technical scope, claim structure, legal status, and the competitive landscape to enable informed decision-making within the pharmaceutical industry.


Patent Overview and Filing Context

SMT202200202 was filed in San Marino, a jurisdiction with a simplified patent process but limited IP enforcement mechanisms compared to larger markets. The patent generally aligns with global pharmaceutical patent strategies, focusing on formulation innovation, therapeutic methods, or novel compounds. Its issuance indicates a strategic intent to safeguard specific innovations, potentially in line with international patent filings under the Patent Cooperation Treaty (PCT).

Although specific filing dates are not listed in the prompt, such patents often emerge after initial R&D phases, targeting regional or global markets. The patent’s grant status, legal life, and renewal history critically influence its commercial value and the scope of protection.


Scope and Claims Analysis

Claim Hierarchy and Structure

The core of any patent’s enforceability resides in its claims, which define the scope of exclusivity. For SMT202200202, the claims likely include:

  1. Independent Claims: These specify broad inventive concepts, such as a novel pharmaceutical compound, a unique formulation, or an innovative therapeutic method.
  2. Dependent Claims: These narrow the scope to specific embodiments, dosages, administration routes, or combination therapies.

Likely Content of the Claims

While the exact wording is unavailable without access to the official patent document, typical claims in such patents might encompass:

  • Novel Compound or Composition: Claims centered on a chemical entity with specific structural features or pharmacological properties.
  • Method of Production: Claims describing manufacturing processes, including synthesis routes or formulation techniques.
  • Therapeutic Method: Claims related to treatment protocols, dosage regimens, or use in specific patient populations.
  • Combination Therapy: Claims covering synergistic combinations with existing drugs.

Scope Considerations

The scope’s breadth determines its enforceability; overly broad claims risk invalidation due to lack of novelty or inventive step, while overly narrow claims limit market exclusivity. Effective claims strike a balance, covering key innovative features without overreach.

Claim Clarity and Patent Quality

Clarity in claim language is vital for enforceability and patent validity. The patent should specify structural formulas, specific dosage ranges, or particular indications to withstand challenges. Ambiguous claims reduce enforceability and open avenues for competitors to design around.


Patent Landscape and Competitive Environment

Global Patent Filings and Priority

Analyzing related patent applications across jurisdictions provides insight into the patent’s strategic importance and potential prior art barriers. Similar patents filed under jurisdictions like the US (via USPTO), Europe (EPO), China (CNIPA), and others could influence the strength of SMT202200202.

Given the global push for innovative therapeutics, the patent landscape often includes:

  • Patent Families: Related applications covering same or similar inventions filed internationally.
  • Prior Art References: Prior disclosures that may challenge novelty or inventive step.
  • Citations: Both citing and cited patents provide insight into technological development and patenting strategies.

Key Patent Families

If SMT202200202 is part of a larger patent family, its coverage might extend to:

  • Method claims at regional levels (e.g., US, EP, CN).
  • Formulation patents covering specific delivery mechanisms.
  • Use patents in particular indications (e.g., oncology, neurology).

Legal Status and Enforcement

San Marino’s patent law requires periodic maintenance, but enforcement relies on regional legal systems. The patent’s validity may be challenged via opposition procedures or post-grant invalidation actions if prior art or claim breadth issues arise.

In countries with robust patent enforcement, such as the US or EU, the patent’s enforceability hinges on its validity and its independence from prior art. In contrast, San Marino’s smaller market offers limited direct commercial leverage but may serve as a stepping stone for regional IP positioning.

Competitive Patent Strategies

Key competitors' patent portfolios in the same therapeutic area influence the landscape. Defensive patenting, patent thickets, or freedom-to-operate analyses are critical for market entry and licensing negotiations.


Regulatory and Market Implications

Patent protection complements regulatory approval pathways, which may include fast-track programs for innovative drugs. Recognizing the scope of patent claims guides strategic positioning—whether to initiate licensing agreements, pursue patent extensions, or develop alternative formulations.

Furthermore, patent strength impacts:

  • Market exclusivity duration.
  • Licensing and partnership potential.
  • Risk of patent infringement litigation.

Conclusion & Strategic Insights

SMT202200202’s patent landscape reflects a typical scenario where claim scope, quality, and jurisdictional coverage define commercial utility. For stakeholders:

  • Maximize claim clarity to ensure enforceability across relevant jurisdictions.
  • Monitor related patent filings to identify potential challenges or opportunities.
  • Leverage patent analysis for licensing negotiations, R&D direction, or market entry planning.
  • Consider fallback strategies such as developing alternative formulations or delivery methods if patent scope is limited.

Key Takeaways

  • The enforceability of SMT202200202 hinges on the clarity, novelty, and inventive step of its claims. A detailed review of the actual claims document is essential for precise assessment.
  • Broader claims extending across jurisdictions increase strategic value, but must be sufficiently supported by supporting data and clear language.
  • The patent landscape's complexity, including related filings and prior art, influences the patent's strength and risk profile.
  • Effective patent positioning aligns with regulatory strategies, potentially providing a competitive edge in the therapeutic area.
  • Continuous monitoring of legal status and competitor activity is vital for maintaining IP security and leveraging licensing or litigation opportunities.

FAQs

1. What is the typical process for enforcing a patent like SMT202200202?
Enforcement involves monitoring potential infringements and initiating legal action through national courts or administrative agencies. The strength of enforcement depends on the clarity and validity of the patent claims, as well as jurisdictional IP laws.

2. Can patents filed in San Marino be extended to other markets?
While San Marino’s patents are valid locally, patent protection in other regions depends on separate filings under national or regional patent offices. Filing via PCT applications can facilitate international protection.

3. How does claim scope affect patent validity?
Claims that are overly broad may be challenged and invalidated for lacking novelty or inventive step. Well-defined, specific claims improve robustness and enforceability.

4. What role do patent citations play in landscape analysis?
Citations identify relevant prior art and related inventions, offering insights into technological development, potential patent conflicts, and innovation trends within the therapeutic area.

5. How might changes in San Marino’s patent law impact patents like SMT202200202?
Legal reforms could modify patent term, scope, or enforcement mechanisms. Staying updated with local law is essential for maintaining the patent’s strategic value.


References

  1. World Intellectual Property Organization (WIPO). "Patent Cooperation Treaty (PCT)." https://www.wipo.int/pct/en/
  2. European Patent Office (EPO). "Guidelines for Examination." https://www.epo.org/law-practice/legal-texts/guidelines.html
  3. US Patent and Trademark Office (USPTO). "Patent Laws and Rules." https://www.uspto.gov/patents/laws
  4. San Marino Intellectual Property Office. "Patent Law and Procedures." (Official source providing local patent law info).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.